Arrowhead Pharmaceuticals (ARWR) Preferred Shares (2011 - 2016)
Arrowhead Pharmaceuticals' (ARWR) quarterly Preferred Shares came in at $16.0 in Q3 2016, little changed YoY from $16.0 in Q4 2015, and little changed on a QoQ basis from $16.0 in Q2 2016.
Analysis
Arrowhead Pharmaceuticals (ARWR) Preferred Shares (2011 - 2016) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 5 years of Preferred Shares data on file, last reported at $16.0 in Q3 2016.
- Quarterly Preferred Shares changed 0.0% year-over-year to $16.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $16.0 (changed 0.0% YoY) and the FY2016 annual result came in at $16.0, changed 0.0% from the prior year.
- Preferred Shares held at $16.0 in Q3 2016, from $16.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $51.0 in Q4 2013 to a low of $10.0 in Q2 2013.
- A 4-year average of $18.64 and a median of $16.0 in 2015 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 110.0% in 2014, down 64.71% in 2014.
- Tracing ARWR's Preferred Shares over 4 years: stood at $51.0 in 2013, then plunged by 64.71% to $18.0 in 2014, then retreated by 11.11% to $16.0 in 2015, then changed by 0.0% to $16.0 in 2016.
- The last three Preferred Shares figures came in at $16.0 (Q3 2016), $16.0 (Q2 2016), and $16.0 (Q1 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 16.00 |
| Jun 30, 2016 | 16.00 |
| Mar 31, 2016 | 16.00 |
| Dec 31, 2015 | 16.00 |
| Sep 30, 2015 | 16.00 |
| Jun 30, 2015 | 16.00 |
| Mar 31, 2015 | 16.00 |
| Dec 31, 2014 | 18.00 |
| Sep 30, 2014 | 18.00 |
| Jun 30, 2014 | 21.00 |
| Mar 31, 2014 | 21.00 |
| Dec 31, 2013 | 51.00 |
| Sep 30, 2013 | 10.00 |
| Jun 30, 2013 | 10.00 |
| Dec 31, 2011 | 1.00 |